Tiziana Life Sciences Short Interest Ratio and Short Volume

Short interest is the volume of Tiziana Life Sciences shares that have been sold short but have not yet been covered or closed out. As of February 12th, traders have sold 213,600 shares of TLSA short.

Tiziana Life Sciences saw a decline in short interest in February. As of February 12th, there was short interest totaling 213,600 shares, a decline of 3.7% from the previous total of 221,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Tiziana Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tiziana Life Sciences: Amphastar Pharmaceuticals, Inc. (7.45%), ADVANZ PHARMA Corp. Limited (0.00%), Dyne Therapeutics, Inc. (5.88%), Esperion Therapeutics, Inc. (35.53%), Collegium Pharmaceutical, Inc. (12.82%), AnaptysBio, Inc. (14.37%), Rigel Pharmaceuticals, Inc. (0.00%), Gossamer Bio, Inc. (13.51%), Merus (0.00%), and Odonate Therapeutics, Inc. (10.99%).

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

Short selling TLSA is an investing strategy that aims to generate trading profit from Tiziana Life Sciences as its price is falling. Tiziana Life Sciences' stock is trading up $0.08 today. To short Tiziana Life Sciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Tiziana Life Sciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tiziana Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLSA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLSA, twice per month. The most recent reporting period available is February, 12 2021.